We are live on ! Find out more
AI

AdvisorShares Investments Portfolio holdings

AUM $549M
1-Year Est. Return 32.58%
This Fund
S&P 500
This Quarter Est. Return
+2.62%
1 Year Est. Return
+32.58%
3 Year Est. Return
+93.4%
5 Year Est. Return
+34.9%
10 Year Est. Return
AUM
$375M
AUM Growth
+$25.3M
Cap. Flow
+$24.2M
Cap. Flow %
6.46%
Top 10 Hldgs %
63.93%
Holding
303
New
49
Increased
67
Reduced
109
Closed
65

Sector Composition

Rank Sector Weight
1 Healthcare 7.66%
2 Consumer Discretionary 6.65%
3 Technology 6.28%
4 Industrials 5.87%
5 Financials 4.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NVDA icon
151
NVIDIA
NVDA
$5.3T
$370K 0.1%
8,500
-1,500
-15% -$67.2K
DFTX
152
Definium Therapeutics
DFTX
$5.85B
$367K 0.1%
117,411
+26,047
+29% +$107K
EXTR icon
153
Extreme Networks
EXTR
$3.14B
$366K 0.1%
15,100
-75
-0.5% -$2.03K
INCR
154
Intercure
INCR
$56.9M
$365K 0.1%
231,045
-2,730
-1% -$4.36K
OLN icon
155
Olin
OLN
$2.12B
$361K 0.1%
+7,217
New +$390K
TT icon
156
Trane Technologies
TT
$105B
$359K 0.1%
+1,771
New +$355K
COF icon
157
Capital One
COF
$134B
$357K 0.1%
3,674
-3,184
-46% -$340K
CTS icon
158
CTS Corp
CTS
$1.88B
$355K 0.09%
8,510
-196
-2% -$8.44K
EVRI
159
DELISTED
Everi Holdings
EVRI
$351K 0.09%
26,517
+3,437
+15% +$48.9K
TPB icon
160
Turning Point Brands
TPB
$1.78B
$345K 0.09%
14,960
-4,666
-24% -$114K
SCHL icon
161
Scholastic
SCHL
$808M
$339K 0.09%
8,894
-204
-2% -$8.47K
ENVB icon
162
Enveric Biosciences
ENVB
$6.2M
$339K 0.09%
816
+258
+46% +$116K
RLMD icon
163
Relmada Therapeutics
RLMD
$492M
$339K 0.09%
112,908
+10
+0% +$30
SAGE
164
DELISTED
Sage Therapeutics
SAGE
$338K 0.09%
16,415
+11,188
+214% +$323K
OEC icon
165
Orion
OEC
$393M
$329K 0.09%
15,466
-356
-2% -$7.77K
TAP icon
166
Molson Coors Class B
TAP
$7.87B
$328K 0.09%
5,158
-1,135
-18% -$73.8K
CCU icon
167
Compañía de Cervecerías Unidas
CCU
$2.22B
$326K 0.09%
25,869
-3,596
-12% -$54.8K
PW
168
Power REIT
PW
$2.93M
$325K 0.09%
27,999
+1,112
+4% +$15.7K
BTI icon
169
British American Tobacco
BTI
$123B
$322K 0.09%
10,240
-1,763
-15% -$58.1K
ITCI
170
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$301K 0.08%
5,772
+1,057
+22% +$61.6K
QNTM
171
Quantum Biopharma Class B Subordinate Voting Shares
QNTM
$24M
$285K 0.08%
3,625
-210
-5% -$17.1K
CRON
172
Cronos Group
CRON
$1.11B
$280K 0.07%
+140,000
New +$274K
LSDI
173
DELISTED
Lucy Scientific Discovery Inc. Common Stock
LSDI
$279K 0.07%
46,600
+18,128
+64% +$157K
VGR
174
DELISTED
Vector Group Ltd.
VGR
$274K 0.07%
25,763
-15,488
-38% -$180K
OKTA icon
175
Okta
OKTA
$26.5B
$269K 0.07%
+3,300
New +$250K

Similar funds

AdvisorShares Investments's Q3 2023 Portfolio in Review

As of Q3 2023, AdvisorShares Investments held 303 positions worth $375M, up 7.2% from $349M the previous quarter. Its ten largest holdings account for 64% of the portfolio.

AdvisorShares Investments deployed $24.2M of net new capital in Q3 2023, opening 49 new positions and adding to 67 existing holdings. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 99,300 shares worth $42.4M.

By sector, the portfolio is most concentrated in Healthcare at 7.7% of assets, down from 7.9% a quarter earlier, followed by Consumer Discretionary and Technology.

On the sell side, the largest reduction was First Trust Nasdaq-100 Select Equal Weight ETF, an estimated $4.38M trimmed.

  • AdvisorShares Investments's largest Q3 2023 buy was State Street SPDR S&P 500 ETF Trust: 99,300 shares worth $42.4M.
  • AdvisorShares Investments added most to Invesco QQQ Trust in Q3 2023, an estimated $38.5M increase.
  • AdvisorShares Investments's biggest Q3 2023 reduction was First Trust Nasdaq-100 Select Equal Weight ETF, cutting an estimated $4.38M.
  • AdvisorShares Investments fully exited Invesco S&P 500 Equal Weight ETF in Q3 2023, selling an estimated $42.3M.
  • AdvisorShares Investments's ten largest holdings make up 64% of its $375M portfolio in Q3 2023.
  • AdvisorShares Investments opened 49 new positions and closed 65 in Q3 2023.
  • AdvisorShares Investments's portfolio value rose 7.2% quarter-over-quarter to $375M.

Based on AdvisorShares Investments's 13F filing for Q3 2023, filed 6 Nov 2023.